Noveris Health Sciences is trading 14.29% down at CA$0.09 amid broader risk aversion, after falling from the September 8 close of CA$0.10.
- No new company-specific announcement or confirmed catalyst was identified for September 9, 2026.
- Recent disclosures involved financing and second-quarter results.
- Weaker major indexes, oil above US$100, and escalating U.S.-Iran tensions appear to be contributing to pressure on speculative equities.